MedPath

GLYSENNID TAB 8.6MG

GLYSENNID TAB 8.6MG

Discontinued
DIN Number

00604402

Drug Class

Human

Market Date

Jan 1, 1979

Company
HC

novartis consumer health canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00604402
AIG Number0107819003
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
A06AB06 SENNA GLYCOSIDES
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification56:12.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

SENNOSIDESActive
Strength: 8.6 MG / TAB
Monograph: SENNOSIDES

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.